Neuromodulation for neuroinflammation treatments with parameters controlled using biomarkers
AssigneeBoston Scientific Neuromodulation Corporation
InventorsBradley Lawrence Hershey, Changfang Zhu
Life of this patent
Estimating the term…
Loading patent…
AssigneeBoston Scientific Neuromodulation Corporation
InventorsBradley Lawrence Hershey, Changfang Zhu
Estimating the term…
An example of a system for modulating neuroinflammation at a tissue site in a patient includes a neuromodulation output circuit, a memory, and a control circuit. The neuromodulation output circuit may be configured to deliver the neuromodulation. The memory may be configured to store a neuromodulation parameter set selected to modulate neural activity at the tissue site and a sensed biomarker parameter. The biomarker parameter may include a measure of a biomarker or a measure of a derivative of the biomarker. The biomarker may be indicative of the neuroinflammation at the tissue site. The control circuit may be configured to control the delivery of the neuromodulation using the neuromodulation parameter set and adjust one or more parameters of the neuromodulation parameter set using the biomarker parameter.
A method for delivering neuromodulation energy to a patient having a spinal cord, the method comprising:
A non-transitory computer-readable storage medium including instructions, which when executed by a system, cause the system to perform a method for delivering neuromodulation energy to a patient having a spinal cord, the method comprising:
A system for delivering neuromodulation energy to a patient having a spinal cord, the system comprising:
Dependencies are inferred from the claim text.